Juvenile Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Juvenile Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-01EMA Authorised: Erelzi (etanercept) — Sandoz GmbH
Authorised status for Erelzi (etanercept) by Sandoz GmbH, expanding access to therapy for multiple inflammatory arthritis conditions.
-
EMA approval · 2026-06-09EMA Authorised: Avtozma (tocilizumab) — Celltrion Healthcare Hungary Kft.
Avtozma (tocilizumab) has been authorised in the EU for rheumatoid arthritis, juvenile idiopathic arthritis, cytokine release syndrome, and …
-
CLINICAL_TRIALS trial_result · 2019-08-02Clinical Trial Update: Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA) [Phase 2, Phase 3]
Clinical trial update on etanercept (TNFR:Fc) in children with Juvenile Rheumatoid Arthritis (Phase 2/Phase 3) with completed status and res…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA [NA]
A completed randomized trial comparing fixed bearing versus mobile bearing cruciate-retaining total knee arthroplasty (TKA) with results pos…